These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 39228151)

  • 1. Single-cell RNA sequencing reveals microenvironmental infiltration in non-small cell lung cancer with different responses to immunotherapy.
    Hu X; Wu Y; Wang L; Yang F; Ye L; Chen X; Song X; Wei P
    J Gene Med; 2024 Sep; 26(9):e3736. PubMed ID: 39228151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insights into the heterogeneity of the tumor microenvironment in lung adenocarcinoma and squamous carcinoma through single-cell transcriptomic analysis: Implications for distinct immunotherapy outcomes.
    Fang X; Li D; Wan S; Hu J; Zhang P; Jie D; Chen L; Jiang G; Song N
    J Gene Med; 2024 Jun; 26(6):e3694. PubMed ID: 38847309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune profiling reveals the diverse nature of the immune response in NSCLC and reveals signaling pathways that may influence the anti-tumor immune response.
    Hamm CA; Pry K; Lu J; Bacus S
    Exp Mol Pathol; 2019 Aug; 109():1-15. PubMed ID: 30953647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic model based on B cell marker genes for NSCLC patients under neoadjuvant immunotherapy by integrated analysis of single-cell and bulk RNA-sequencing data.
    Liu Y; Bie F; Bai G; Huai Q; Li Y; Chen X; Zhou B; Gao S
    Clin Transl Oncol; 2024 Aug; 26(8):2025-2036. PubMed ID: 38563846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of poor prognostic immune features of tumour microenvironment in non-smoking patients with lung adenocarcinoma.
    Kinoshita T; Kudo-Saito C; Muramatsu R; Fujita T; Saito M; Nagumo H; Sakurai T; Noji S; Takahata E; Yaguchi T; Tsukamoto N; Hayashi Y; Kaseda K; Kamiyama I; Ohtsuka T; Tomizawa K; Shimoji M; Mitsudomi T; Asamura H; Kawakami Y
    Eur J Cancer; 2017 Nov; 86():15-27. PubMed ID: 28950145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the CD8 + T-cell Related Signature for Predicting the Prognosis of Gastric Cancer Based on Integrated Analysis of Bulk and Single-cell RNA Sequencing Data.
    Zhu ZG; Wang Z; Wu Q; Miao DL; Jin YQ; Chen L
    J Immunother; 2024 Sep; 47(7):239-248. PubMed ID: 38809517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor microenvironment remodeling after neoadjuvant immunotherapy in non-small cell lung cancer revealed by single-cell RNA sequencing.
    Hu J; Zhang L; Xia H; Yan Y; Zhu X; Sun F; Sun L; Li S; Li D; Wang J; Han Y; Zhang J; Bian D; Yu H; Chen Y; Fan P; Ma Q; Jiang G; Wang C; Zhang P
    Genome Med; 2023 Mar; 15(1):14. PubMed ID: 36869384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of JUN gene and cellular microenvironment in response to PD-1 blockade treatment in lung cancer patients via single-cell RNA sequencing.
    Wang Y; Ran T; Li Y; Tian L; Yang L; Liu Z; Yao B
    Aging (Albany NY); 2024 Jun; 16(12):10348-10365. PubMed ID: 38874497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-cell RNA sequencing reveals compartmental remodeling of tumor-infiltrating immune cells induced by anti-CD47 targeting in pancreatic cancer.
    Pan Y; Lu F; Fei Q; Yu X; Xiong P; Yu X; Dang Y; Hou Z; Lin W; Lin X; Zhang Z; Pan M; Huang H
    J Hematol Oncol; 2019 Nov; 12(1):124. PubMed ID: 31771616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The implications of clinical risk factors, CAR index, and compositional changes of immune cells on hyperprogressive disease in non-small cell lung cancer patients receiving immunotherapy.
    Kim SR; Chun SH; Kim JR; Kim SY; Seo JY; Jung CK; Gil BM; Kim JO; Ko YH; Woo IS; Shim BY; Hong SH; Kang JH
    BMC Cancer; 2021 Jan; 21(1):19. PubMed ID: 33402127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Immunogram for the Cancer-Immunity Cycle: Towards Personalized Immunotherapy of Lung Cancer.
    Karasaki T; Nagayama K; Kuwano H; Nitadori JI; Sato M; Anraku M; Hosoi A; Matsushita H; Morishita Y; Kashiwabara K; Takazawa M; Ohara O; Kakimi K; Nakajima J
    J Thorac Oncol; 2017 May; 12(5):791-803. PubMed ID: 28088513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic profiles and their associations with TMB, PD-L1 expression, and immune cell infiltration landscapes in synchronous multiple primary lung cancers.
    Hu C; Zhao L; Liu W; Fan S; Liu J; Liu Y; Liu X; Shu L; Liu X; Liu P; Deng C; Qiu Z; Chen C; Jiang Y; Liang Q; Yang L; Shao Y; He Q; Yu D; Zeng Y; Li Y; Pan Y; Zhang S; Shi S; Peng Y; Wu F
    J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34887263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-cell RNA sequencing reveals distinct tumor microenvironmental patterns in lung adenocarcinoma.
    Bischoff P; Trinks A; Obermayer B; Pett JP; Wiederspahn J; Uhlitz F; Liang X; Lehmann A; Jurmeister P; Elsner A; Dziodzio T; Rückert JC; Neudecker J; Falk C; Beule D; Sers C; Morkel M; Horst D; Blüthgen N; Klauschen F
    Oncogene; 2021 Dec; 40(50):6748-6758. PubMed ID: 34663877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PD-L1 expression and T cells infiltration in patients with uncommon EGFR-mutant non-small cell lung cancer and the response to immunotherapy.
    Chen K; Cheng G; Zhang F; Zhu G; Xu Y; Yu X; Huang Z; Fan Y
    Lung Cancer; 2020 Apr; 142():98-105. PubMed ID: 32120230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereotactic Body Radiotherapy Is Effective in Modifying the Tumor Genome and Tumor Immune Microenvironment in Non-Small Cell Lung Cancer or Lung Metastatic Carcinoma.
    Zhou P; Chen D; Zhu B; Chen W; Xie Q; Wang Y; Tan Q; Yuan B; Zuo X; Huang C; Zhu H; Li G
    Front Immunol; 2020; 11():594212. PubMed ID: 33552051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ADGRE5-centered Tsurv model in T cells recognizes responders to neoadjuvant cancer immunotherapy.
    Li J; Meng Z; Cao Z; Lu W; Yang Y; Li Z; Lu S
    Front Immunol; 2024; 15():1304183. PubMed ID: 38343549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-cell transcriptomics reveals a low CD8
    Peng YL; Xiong LB; Zhou ZH; Ning K; Li Z; Wu ZS; Deng MH; Wei WS; Wang N; Zou XP; He ZS; Huang JW; Luo JH; Liu JY; Jia N; Cao Y; Han H; Guo SJ; Dong P; Yu CP; Zhou FJ; Zhang ZL
    J Immunother Cancer; 2022 Feb; 10(2):. PubMed ID: 35121646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. scRNA+ TCR-seq revealed dual TCR T cells antitumor response in the TME of NSCLC.
    Peng Q; Xu Y; Yao X
    J Immunother Cancer; 2024 Sep; 12(9):. PubMed ID: 39237261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Programmed cell death ligand-1 (PD-L1) expression combined with CD8 tumor infiltrating lymphocytes density in non-small cell lung cancer patients.
    El-Guindy DM; Helal DS; Sabry NM; Abo El-Nasr M
    J Egypt Natl Canc Inst; 2018 Dec; 30(4):125-131. PubMed ID: 30337185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of adhesion molecules and barrier molecules is associated with differential infiltration of immune cells in non-small cell lung cancer.
    Chae YK; Choi WM; Bae WH; Anker J; Davis AA; Agte S; Iams WT; Cruz M; Matsangou M; Giles FJ
    Sci Rep; 2018 Jan; 8(1):1023. PubMed ID: 29348685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.